Search Results 271-280 of 16327 for immunothérapie Bylaska
No prior immunotherapy for advanced/metastatic MCC; Patients with known or suspected central nervous system (CNS) metastases, untreated CNS metastases, or ...
Panitumumab injection is used alone or in combination with other medicines to treat metastatic cancer (cancer that spreads to other parts of the body) of the ...
... immunotherapy for treatment of their cancer. Subject must have had, or will have, a tumor biopsy prior to treatment with anti-PD-1/PD-L1 immunotherapy.
These include targeted therapy, immunotherapy, CAR-T cell therapy, bone marrow transplant and clinical trials. Your care team works with you to understand ...
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
The purpose of this study is to evaluate the long-term safety in patients previously treated with Medeor cellular immunotherapy products in a Medeor parent ...
Participation eligibility · Prior exposure to any chemotherapy, PARPi, or immunotherapy for prostate cancer. · Pure Small Cell Carcinoma. · Prior abiraterone, ...
... immunotherapy before surgery, and immunotherapy after surgery works better than standard adjuvant therapy for treating patients with high-risk, stage 3 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.